跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,405 条关于
“Sparrow Ascent”
全部
6,405
临床试验
5,764
药物
178
机构
44
资讯
419
去年
Health Canada Approves Spark Biomedical's Drug-Free Neurostimulation Device for Opioid Withdrawal
2年前
Spark Biomedical Receives NIDA Funding to Develop AI for Opioid Withdrawal Detection
去年
Air Force and Spark Biomedical Launch Trial to Combat Motion Sickness Using Neurostimulation Technology
去年
Sparrow Pharmaceuticals' Clofutriben Completes Phase 2 Trial and Receives FDA Orphan Drug Designation for Cushing's Syndrome
上个月
Sparrow Pharmaceuticals Bets Cortisol, Not GLP-1, Is the Next Frontier in Type 2 Diabetes
8个月前
Sparrow Pharmaceuticals Initiates Phase 2b Trial of Clofutriben for Difficult-to-Control Type 2 Diabetes
去年
First Ascent Biomedical Secures Florida Grant to Expand AI-Driven Cancer Treatment Platform
2个月前
First Ascent Biomedical Appoints Raymond Rodriguez-Torres as President to Scale Functional Precision Oncology Platform
11个月前
Sparrow Pharmaceuticals Secures $95 Million Series B to Advance Novel Diabetes Treatment Targeting Elevated Cortisol
去年
First Ascent Biomedical Partners with Fight Colorectal Cancer for $350,000 Precision Medicine Study
第 1 页,共 42 页
上一页
下一页